105 related articles for article (PubMed ID: 11798168)
1. Glycogen synthase kinase-3 inhibition by lithium and beryllium suggests the presence of two magnesium binding sites.
Ryves WJ; Dajani R; Pearl L; Harwood AJ
Biochem Biophys Res Commun; 2002 Jan; 290(3):967-72. PubMed ID: 11798168
[TBL] [Abstract][Full Text] [Related]
2. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.
Ryves WJ; Harwood AJ
Biochem Biophys Res Commun; 2001 Jan; 280(3):720-5. PubMed ID: 11162580
[TBL] [Abstract][Full Text] [Related]
3. Beryllium is an inhibitor of cellular GSK-3β that is 1,000-fold more potent than lithium.
Mudireddy SR; Abdul AR; Gorjala P; Gary RK
Biometals; 2014 Dec; 27(6):1203-16. PubMed ID: 25104312
[TBL] [Abstract][Full Text] [Related]
4. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells.
Stambolic V; Ruel L; Woodgett JR
Curr Biol; 1996 Dec; 6(12):1664-8. PubMed ID: 8994831
[TBL] [Abstract][Full Text] [Related]
5. P24, a glycogen synthase kinase 3 (GSK 3) inhibitor.
Martín CP; Vázquez J; Avila J; Moreno FJ
Biochim Biophys Acta; 2002 Jan; 1586(1):113-22. PubMed ID: 11781156
[TBL] [Abstract][Full Text] [Related]
6. The use of beta, gamma-methyleneadenosine 5'-triphosphate to determine ATP competition in a scintillation proximity kinase assay.
Peterson MF; Martin WH; Spencer RW; Tate BF
Anal Biochem; 1999 Jul; 271(2):131-6. PubMed ID: 10419627
[TBL] [Abstract][Full Text] [Related]
7. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
Takahashi M; Yasutake K; Tomizawa K
J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
[TBL] [Abstract][Full Text] [Related]
8. Lithium chloride inhibits the expression and secretion of insulin-like growth factor-binding protein-1.
Lewitt MS; Brismar K; Ohlson J; Hartman J
J Endocrinol; 2001 Dec; 171(3):R11-5. PubMed ID: 11739024
[TBL] [Abstract][Full Text] [Related]
9. First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.
Martinez A; Alonso M; Castro A; Pérez C; Moreno FJ
J Med Chem; 2002 Mar; 45(6):1292-9. PubMed ID: 11881998
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent.
Meijer L; Thunnissen AM; White AW; Garnier M; Nikolic M; Tsai LH; Walter J; Cleverley KE; Salinas PC; Wu YZ; Biernat J; Mandelkow EM; Kim SH; Pettit GR
Chem Biol; 2000 Jan; 7(1):51-63. PubMed ID: 10662688
[TBL] [Abstract][Full Text] [Related]
11. An assay for glycogen synthase kinase 3 (GSK-3) for use in crude cell extracts.
Ryves WJ; Fryer L; Dale T; Harwood AJ
Anal Biochem; 1998 Nov; 264(1):124-7. PubMed ID: 9784196
[No Abstract] [Full Text] [Related]
12. Lithium inhibits function of voltage-dependent sodium channels and catecholamine secretion independent of glycogen synthase kinase-3 in adrenal chromaffin cells.
Yanagita T; Maruta T; Uezono Y; Satoh S; Yoshikawa N; Nemoto T; Kobayashi H; Wada A
Neuropharmacology; 2007 Dec; 53(7):881-9. PubMed ID: 17950380
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of protein L-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization.
Lamarre M; Desrosiers RR
Neuropharmacology; 2008 Oct; 55(5):669-76. PubMed ID: 18582478
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation.
Martinez A; Castro A; Dorronsoro I; Alonso M
Med Res Rev; 2002 Jul; 22(4):373-84. PubMed ID: 12111750
[TBL] [Abstract][Full Text] [Related]
15. A molecular mechanism for the effect of lithium on development.
Klein PS; Melton DA
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8455-9. PubMed ID: 8710892
[TBL] [Abstract][Full Text] [Related]
16. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.
Hoeflich KP; Luo J; Rubie EA; Tsao MS; Jin O; Woodgett JR
Nature; 2000 Jul; 406(6791):86-90. PubMed ID: 10894547
[TBL] [Abstract][Full Text] [Related]
17. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.
Silva R; Mesquita AR; Bessa J; Sousa JC; Sotiropoulos I; Leão P; Almeida OF; Sousa N
Neuroscience; 2008 Mar; 152(3):656-69. PubMed ID: 18291594
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase 3: an emerging therapeutic target.
Eldar-Finkelman H
Trends Mol Med; 2002 Mar; 8(3):126-32. PubMed ID: 11879773
[TBL] [Abstract][Full Text] [Related]
19. Comparison of fluorescence, (31)P NMR, and (7)Li NMR spectroscopic methods for investigating Li(+)/Mg(2+) competition for biomolecules.
Amari L; Layden B; Rong Q; Geraldes CF; Mota de Freitas D
Anal Biochem; 1999 Jul; 272(1):1-7. PubMed ID: 10405286
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo.
Noble W; Planel E; Zehr C; Olm V; Meyerson J; Suleman F; Gaynor K; Wang L; LaFrancois J; Feinstein B; Burns M; Krishnamurthy P; Wen Y; Bhat R; Lewis J; Dickson D; Duff K
Proc Natl Acad Sci U S A; 2005 May; 102(19):6990-5. PubMed ID: 15867159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
